Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Neuropsychopharmacol ; 18(6)2014 Dec 28.
Article in English | MEDLINE | ID: mdl-25548106

ABSTRACT

BACKGROUND: The acylethanolamides oleoylethanolamide and palmitoylethanolamide are endogenous lipid mediators with proposed neuroprotectant properties in central nervous system (CNS) pathologies. The precise mechanisms remain partly unknown, but growing evidence suggests an antiinflammatory/antioxidant profile. METHODS: We tested whether oleoylethanolamide/palmitoylethanolamide (10 mg/kg, i.p.) attenuate neuroinflammation and acute phase responses (hypothalamus-pituitary-adrenal (HPA) stress axis stress axis activation, thermoregulation, and anhedonia) induced by lipopolysaccharide (0.5 mg/kg, i.p.) in rats. RESULTS: Lipopolysaccharide increased mRNA levels of the proinflammatory cytokines tumor necrosis factor-α, interleukin-1ß, and interleukin-6, nuclear transcription factor-κB activity, and the expression of its inhibitory protein IκBα in cytoplasm, the inducible isoforms of nitric oxide synthase and cyclooxygenase-2, microsomal prostaglandin E2 synthase mRNA, and proinflammatory prostaglandin E2 content in frontal cortex 150 minutes after administration. As a result, the markers of nitrosative/oxidative stress nitrites (NO2(-)) and malondialdehyde were increased. Pretreatment with oleoylethanolamide/ palmitoylethanolamide reduced plasma tumor necrosis factor-α levels after lipopolysaccharide, but only oleoylethanolamide significantly reduced brain tumor necrosis factor-α mRNA. Oleoylethanolamide and palmitoylethanolamide prevented lipopolysaccharide-induced nuclear transcription factor-κB (NF-κB)/IκBα upregulation in nuclear and cytosolic extracts, respectively, the expression of inducible isoforms of nitric oxide synthase, cyclooxygenase-2, and microsomal prostaglandin E2 synthase and the levels of prostaglandin E2. Additionally, both acylethanolamides reduced lipopolysaccharide-induced oxidative/nitrosative stress. Neither oleoylethanolamide nor palmitoylethanolamide modified plasma corticosterone levels after lipopolysaccharide, but both acylethanolamides reduced the expression of hypothalamic markers of thermoregulation interleukin-1ß, cyclooxygenase-2, and prostaglandin E2, and potentiated the hypothermic response after lipopolysaccharide. Interestingly, only oleoylethanolamide disrupted lipopolysaccharide-induced anhedonia in a saccharine preference test. CONCLUSIONS: Results indicate that oleoylethanolamide and palmitoylethanolamide have antiinflammatory/neuroprotective properties and suggest a role for these acylethanolamides as modulators of CNS pathologies with a neuroinflammatory component.


Subject(s)
Anhedonia/drug effects , Anti-Inflammatory Agents/administration & dosage , Behavior, Animal/drug effects , Brain/drug effects , Encephalitis/prevention & control , Endocannabinoids/administration & dosage , Endotoxins , Neuroprotective Agents/administration & dosage , Oleic Acids/administration & dosage , Amides , Animals , Body Temperature Regulation/drug effects , Brain/metabolism , Brain/physiopathology , Corticosterone/blood , Cytokines/genetics , Cytokines/metabolism , Disease Models, Animal , Encephalitis/chemically induced , Encephalitis/genetics , Encephalitis/metabolism , Encephalitis/physiopathology , Encephalitis/psychology , Ethanolamines/administration & dosage , Food Preferences , Frontal Lobe/drug effects , Frontal Lobe/metabolism , Frontal Lobe/physiopathology , Hypothalamo-Hypophyseal System/drug effects , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Inflammation Mediators/metabolism , Lipid Peroxidation/drug effects , Male , Oxidative Stress/drug effects , Palmitic Acids/administration & dosage , Pituitary-Adrenal System/drug effects , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/physiopathology , Rats, Wistar , Taste Perception/drug effects
2.
Biol Psychiatry ; 73(1): 32-43, 2013 Jan 01.
Article in English | MEDLINE | ID: mdl-22906518

ABSTRACT

BACKGROUND: Stressful challenges are associated with variations in immune parameters, including increased innate immunity/inflammation. Among possible mechanisms through which brain monitors peripheral immune responses, toll-like receptors (TLRs) recently emerged as the first line of defense against invading microorganisms. Their expression is modulated in response to pathogens and other environmental stresses. METHODS: Taking into account this background, the present study aimed to elucidate whether the toll-like receptor-4 (TLR-4) signaling pathway is activated after repeated restraint/acoustic stress exposure in mice prefrontal cortex (PFC), the potential regulatory mechanism implicated (i.e., bacterial translocation), and its role in conditions of stress-induced neuroinflammation, using a genetic strategy: C3H/HeJ mice with a defective response to lipopolysaccharide stimulation of TLR-4. RESULTS: Stress exposure upregulates TLR-4 pathway in mice PFC. Stress-induced inflammatory nuclear factor κB activation, upregulation of the proinflammatory enzymes nitric oxide synthase and cyclooxygenase type 2, and cellular oxidative/nitrosative damage are reduced when the TLR-4 pathway is defective. Conversely, TLR-4 deficient mice presented higher levels of the anti-inflammatory nuclear factor peroxisome proliferator activated receptor-gamma after stress exposure than control mice. The series of experiments using antibiotic intestinal decontamination also suggest a role for bacterial translocation on TLR-4 activation in PFC after stress exposure. CONCLUSIONS: Taken together, all the data presented here suggest a bifunctional role of TLR-4 signaling pathway after stress exposure by triggering neuroinflammation at PFC level and regulating gut barrier function/permeability. Furthermore, our data suggest a possible protective role of antibiotic decontamination in stress-related pathologies presenting increased intestinal permeability (leaky gut) such as depression, showing a potential therapeutic target that deserves further consideration.


Subject(s)
Inflammation/metabolism , Stress, Psychological/physiopathology , Toll-Like Receptor 4/physiology , Acute-Phase Proteins/metabolism , Animals , Bacterial Translocation/drug effects , Bacterial Translocation/physiology , Carrier Proteins/metabolism , Colon/metabolism , Immunoglobulin A/metabolism , Inflammation/blood , Inflammation/complications , Inflammation Mediators/metabolism , Lipopolysaccharides/metabolism , Male , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred C3H , Prefrontal Cortex/metabolism , Signal Transduction/physiology , Stress, Psychological/blood , Stress, Psychological/complications , Stress, Psychological/metabolism , Toll-Like Receptor 4/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...